(Q38117062)

29 August 2017

title

Depression in peri- and postmenopausal women: prevalence, pathophysiology and pharmacological management (English)

1 reference

29 August 2017

1 reference

1 reference

Claudio N Soares

1

1 reference

29 August 2017

publication date

1 September 2013

1 reference

29 August 2017

1 reference

29 August 2017

volume

30

1 reference

29 August 2017

issue

9

1 reference

29 August 2017

page(s)

677-685

1 reference

Sex and depression in the National Comorbidity Survey. I: Lifetime prevalence, chronicity and recurrence

29 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0100-1

Childhood and adolescent depression: a review of the past 10 years. Part I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0100-1

The influence of age and sex on the prevalence of depressive conditions: report from the National Survey of Psychiatric Morbidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0100-1

Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0100-1

Prevalence, incidence and stability of premenstrual dysphoric disorder in the community

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0100-1

Risk factors for early postpartum depressive symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0100-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0100-1

Burden of disease--implications for future research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0100-1

Estrogen-serotonin interactions: implications for affective regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0100-1

Hormones and mood: from menarche to menopause and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0100-1

Prevalence of mood and anxiety disorders in women who seek treatment for premenstrual syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0100-1

Associations of hormones and menopausal status with depressed mood in women with no history of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0100-1

Risk for New Onset of Depression During the Menopausal Transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0100-1

Menopausal transition and depression: who is at risk and how to treat it?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0100-1

Racial/ethnic differences in the prevalence of depressive symptoms among middle-aged women: The Study of Women's Health Across the Nation (SWAN).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0100-1

Prevalence of depression and anxiety symptoms and their influence factors during menopausal transition and postmenopause in Beijing city.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0100-1

Sexual and psychological symptoms in the climacteric years

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0100-1

Depressive symptoms during the menopausal transition: the Study of Women's Health Across the Nation (SWAN).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0100-1

Estrogen actions in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0100-1

From menarche to menopause: exploring the underlying biology of depression in women experiencing hormonal changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0100-1

Estrogen, menopause, and the aging brain: how basic neuroscience can inform hormone therapy in women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0100-1

Differential distribution and regulation of estrogen receptor-alpha and -beta mRNA within the female rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0100-1

Estrogen receptors and human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0100-1

GPR30: a novel therapeutic target in estrogen-related disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0100-1

The rapid effects of estrogen: a mini-review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0100-1

Ovarian steroid regulation of monoamine oxidase-A and -B mRNAs in the macaque dorsal raphe and hypothalamic nuclei

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0100-1

Effects of oral estrogen, raloxifene and arzoxifene on gene expression in serotonin neurons of macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0100-1

Estrogen selectively increases tryptophan hydroxylase-2 mRNA expression in distinct subregions of rat midbrain raphe nucleus: association between gene expression and anxiety behavior in the open field

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0100-1

Serotonin 1A receptor reductions in postpartum depression: a positron emission tomography study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0100-1

Gonadal hormones modulate 5-hydroxytryptamine2A receptors: emphasis on the rat frontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0100-1

Estradiol-17 beta increases serotonin transporter (SERT) mRNA levels and the density of SERT-binding sites in female rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0100-1

Hot flashes: behavioral treatments, mechanisms, and relation to sleep

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0100-1

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0100-1

Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0100-1

Postmenopausal hormone therapy: an Endocrine Society scientific statement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0100-1

The Women's Health Initiative Memory Study: findings and implications for treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0100-1

Lack of efficacy of estradiol for depression in postmenopausal women: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0100-1

Long-term risk of depressive and anxiety symptoms after early bilateral oophorectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0100-1

Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a double-blind, randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0100-1

Estrogen-replacement therapy for depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0100-1

Short-term use of estradiol for depression in perimenopausal and postmenopausal women: a preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0100-1

Estrogen replacement therapy and antidepressant response to sertraline in older depressed women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0100-1

Estrogen replacement and response to fluoxetine in a multicenter geriatric depression trial. Fluoxetine Collaborative Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0100-1

Relative antidepressant efficacy of venlafaxine and SSRIs: sex-age interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0100-1

Hormone replacement therapy and antidepressant prescription patterns: a reciprocal relationship.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0100-1

Global consensus statement on menopausal hormone therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0100-1

Augmentation of venlafaxine and selective serotonin reuptake inhibitors with zolpidem improves sleep and quality of life in breast cancer patients with hot flashes: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0100-1

Escitalopram versus ethinyl estradiol and norethindrone acetate for symptomatic peri- and postmenopausal women: impact on depression, vasomotor symptoms, sleep, and quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0100-1

An open trial of mirtazapine in menopausal women with depression unresponsive to estrogen replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0100-1

Short-Term Efficacy and Safety of Desvenlafaxine in a Randomized, Placebo-Controlled Study of Perimenopausal and Postmenopausal Women With Major Depressive Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0100-1

Assessing the efficacy of desvenlafaxine for improving functioning and well-being outcome measures in patients with major depressive disorder: a pooled analysis of 9 double-blind, placebo-controlled, 8-week clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0100-1

A pilot, 8-week, placebo lead-in trial of quetiapine extended release for depression in midlife women: impact on mood and menopause-related symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0100-1

Effects of quetiapine extended release on sleep and quality of life in midlife women with major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0100-1

Prevalence of insomnia and associated socio-demographic factors in a Brazilian community: the Bambuı́ study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0100-1

Subjective measurement of insomnia and quality of life in depressed inpatients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0100-1

The impact of chronic pain on depression, sleep, and the desire to withdraw from dialysis in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0100-1

Relationship between chronic painful physical condition and insomnia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0100-1

Symptoms during cancer pain treatment following WHO-guidelines: a longitudinal follow-up study of symptom prevalence, severity and etiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0100-1

Depression is associated with worse objectively and subjectively measured sleep, but not more frequent awakenings, in women with vasomotor symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0100-1

Evaluation and Management of Sleep Disturbance during the Menopause Transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0100-1

Double-blind, placebo-controlled, hormonal, syndromal and EEG mapping studies with transdermal oestradiol therapy in menopausal depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0100-1

Sleep in menopause: differential effects of two forms of hormone replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0100-1

Effects of low-dose, continuous combined estradiol and noretisterone acetate on menopausal quality of life in early postmenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0100-1

Effect of zolpidem on sleep in women with perimenopausal and postmenopausal insomnia: a 4-week, randomized, multicenter, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0100-1

Eszopiclone in patients with insomnia during perimenopause and early postmenopause: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0100-1

Menopausal transition, mood, and cognition: an integrated view to close the gaps

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0100-1

The menopausal transition

21 January 2018

1 reference

12 December 2020

Effects of estrogen on the central nervous system.

1 reference

12 December 2020

Fluoxetine efficacy in menopausal women with and without estrogen replacement

1 reference

12 December 2020

Desvenlafaxine and escitalopram for the treatment of postmenopausal women with major depressive disorder

1 reference

12 December 2020

Estrogen replacement in perimenopause-related depression: a preliminary report

1 reference

12 December 2020

Effects of media coverage of Women's Health Initiative study on attitudes and behavior of women receiving hormone replacement therapy.

1 reference

12 December 2020

Efficacy of Citalopram as a Monotherapy or as an Adjunctive Treatment to Estrogen Therapy for Perimenopausal and Postmenopausal Women With Depression and Vasomotor Symptoms

1 reference

12 December 2020

Treatment of depression and menopause-related symptoms with the serotonin-norepinephrine reuptake inhibitor duloxetine

1 reference

12 December 2020

Psychologic distress and natural menopause: a multiethnic community study

1 reference

12 December 2020

Sleep disturbance during the menopausal transition in a multi-ethnic community sample of women.

1 reference

12 December 2020

Serotonergic and noradrenergic receptors in the rat brain: Modulation by chronic exposure to ovarian hormones

1 reference

12 December 2020

Effects of chronic 17beta-estradiol treatment on the serotonin 5-HT(1A) receptor mRNA and binding levels in the rat brain

1 reference

12 December 2020

Depression during the menopausal transition: window of vulnerability or continuum of risk?

1 reference

12 December 2020

Premenstrual syndrome

1 reference

12 December 2020

Oestrogen upregulates noradrenaline release in the mediobasal hypothalamus and tyrosine hydroxylase gene expression in the brainstem of ovariectomized rhesus macaques

1 reference

12 December 2020

Sleep disturbances in a young adult population: can gender differences be explained by differences in psychological status?

1 reference

12 December 2020

Chronic insomnia as a risk factor for developing anxiety and depression

1 reference

12 December 2020

Sleep habits and insomnia in a sample of elderly persons in China.

1 reference

12 December 2020

Sleep complaints among elderly persons: an epidemiologic study of three communities.

1 reference

12 December 2020

Reproductive hormone sensitivity and risk for depression across the female life cycle: a continuum of vulnerability?

1 reference

12 December 2020

Endocrinology of menopausal transition and its brain implications.

1 reference

12 December 2020

10.1007/S40266-013-0100-1

Identifiers

DOI

1 reference

29 August 2017

1 reference